INDO-GLOBAL ENT. | GLOBAL LONGLIFE | INDO-GLOBAL ENT./ GLOBAL LONGLIFE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -31.9 | - | - | View Chart |
P/BV | x | 1.4 | 0.7 | 219.7% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO-GLOBAL ENT. GLOBAL LONGLIFE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO-GLOBAL ENT. Mar-20 |
GLOBAL LONGLIFE Mar-23 |
INDO-GLOBAL ENT./ GLOBAL LONGLIFE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 20 | 141 | 14.5% | |
Low | Rs | 20 | 40 | 51.0% | |
Sales per share (Unadj.) | Rs | 0 | 22.4 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.7 | 1.7 | -37.6% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 2.9 | -23.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 11.1 | 61.2 | 18.1% | |
Shares outstanding (eoy) | m | 6.37 | 10.50 | 60.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 4.0 | - | |
Avg P/E ratio | x | -31.1 | 52.0 | -59.8% | |
P/CF ratio (eoy) | x | -31.1 | 31.8 | -98.0% | |
Price / Book Value ratio | x | 1.8 | 1.5 | 124.3% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 130 | 951 | 13.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 30 | 1.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 235 | 0.0% | |
Other income | Rs m | 0 | 2 | 0.0% | |
Total revenues | Rs m | 0 | 237 | 0.0% | |
Gross profit | Rs m | -1 | 41 | -3.6% | |
Depreciation | Rs m | 0 | 12 | 0.0% | |
Interest | Rs m | 1 | 4 | 16.0% | |
Profit before tax | Rs m | -2 | 27 | -8.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | 9 | 23.0% | |
Profit after tax | Rs m | -4 | 18 | -22.8% | |
Gross profit margin | % | 0 | 17.3 | - | |
Effective tax rate | % | -93.4 | 32.5 | -287.4% | |
Net profit margin | % | 0 | 7.8 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 335 | 0.0% | |
Current liabilities | Rs m | 7 | 78 | 8.8% | |
Net working cap to sales | % | 0 | 109.3 | - | |
Current ratio | x | 0 | 4.3 | 0.1% | |
Inventory Days | Days | 0 | 315 | - | |
Debtors Days | Days | 0 | 1,506 | - | |
Net fixed assets | Rs m | 80 | 379 | 21.1% | |
Share capital | Rs m | 64 | 105 | 60.7% | |
"Free" reserves | Rs m | 7 | 538 | 1.3% | |
Net worth | Rs m | 71 | 643 | 11.0% | |
Long term debt | Rs m | 2 | 36 | 6.6% | |
Total assets | Rs m | 80 | 738 | 10.8% | |
Interest coverage | x | -2.1 | 7.3 | -29.1% | |
Debt to equity ratio | x | 0 | 0.1 | 59.7% | |
Sales to assets ratio | x | 0 | 0.3 | 0.0% | |
Return on assets | % | -4.4 | 3.1 | -142.2% | |
Return on equity | % | -5.9 | 2.8 | -207.8% | |
Return on capital | % | -2.0 | 4.6 | -43.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | -404 | 0.3% | |
From Investments | Rs m | NA | -19 | -0.0% | |
From Financial Activity | Rs m | 1 | 457 | 0.3% | |
Net Cashflow | Rs m | 0 | 34 | 0.0% |
Indian Promoters | % | 2.8 | 54.3 | 5.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 97.2 | 45.7 | 212.6% | |
Shareholders | 543 | 947 | 57.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO-GLOBAL ENT. With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE KIMS NARAYANA HRUDAYALAYA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO-GLOBAL ENT. | GLOBAL LONGLIFE |
---|---|---|
1-Day | -4.76% | -1.03% |
1-Month | 6.24% | -4.40% |
1-Year | -13.28% | -13.57% |
3-Year CAGR | -7.78% | -33.29% |
5-Year CAGR | -4.74% | -21.56% |
* Compound Annual Growth Rate
Here are more details on the INDO-GLOBAL ENT. share price and the GLOBAL LONGLIFE share price.
Moving on to shareholding structures...
The promoters of INDO-GLOBAL ENT. hold a 2.8% stake in the company. In case of GLOBAL LONGLIFE the stake stands at 54.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO-GLOBAL ENT. and the shareholding pattern of GLOBAL LONGLIFE.
Finally, a word on dividends...
In the most recent financial year, INDO-GLOBAL ENT. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
GLOBAL LONGLIFE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO-GLOBAL ENT., and the dividend history of GLOBAL LONGLIFE.
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.